Patients with relapsed acute lymphoblastic leukemia (ALL) have an extremely poor prognosis. Patients with acute lymphoblastic leukemia (ALL) who...

The question is essentialy about the appropriateness of dropping cisplatin and continuing what the providers called "maintenance"...

Millman considers a one day admission appropriate for acute coronary syndrome. This is an umbrella term used to cover any group of clinical symptoms...

Tarceva is currently FDA approved for pancreatic cancer in combination with gemcitabine and for non-small cell lung cancer for second line. There...

Revlimid is a derivative of thalidomide with less toxic side effects. A multicenter U.S. trial has reported hematologic activity of Revlimid in...